Results 181 to 190 of about 14,077 (253)

The Diversity of Methylation Patterns in Serous Borderline Ovarian Tumors and Serous Ovarian Carcinomas. [PDF]

Cancers (Basel)
Szafron LA, Iwanicka-Nowicka R, Sobiczewski P, Koblowska M, Dansonka-Mieszkowska A, Kupryjanczyk J, Szafron LM.   +6 more
europepmc   +1 more source

Borderline ovarian tumors: Cystectomy or oophorectomy

Taiwanese Journal of Obstetrics and Gynecology
Peng-Hui Wang, Wen-Ling Lee
openaire   +2 more sources

Borderline Ovarian Serous Tumor [PDF]

, 2020
openaire   +1 more source

Bioinformatics Identification of lncRNA‐Associated Molecular Signatures Potentially Related to Quercetin Response in Breast Cancer

Computational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT Breast cancer affects approximately one in every eight women globally, as reported by the World Health Organization. Among all female malignant tumors, breast cancer has the highest fatality rate, surpassed only by lung cancer. Advanced stages of this disease are almost always fatal, and despite the advancements in surgical techniques and ...
Mahboobeh Mehrabani Natanzi, Zohreh Khodaii, Naghmeh Zhalehjoo   +2 more
wiley   +1 more source

Transvaginal natural orifice transluminal endoscopic surgery for early-stage ovarian cancer and borderline ovarian tumors: a case series. [PDF]

Front Surg
Kellerhals G, Nef J, Hurni Y, Huber D.
europepmc   +1 more source

Experiment‐Anchored Abundance–Coverage Frontiers Define Conditional RHSVV Exposure Requirements in TP53‐Missense Tumors

Computational and Systems Oncology, Volume 6, Issue 1, December 2026.
ABSTRACT Mutant p53 accumulation may complement conformation‐sensitive RHSVV recognition, but the required exposure discrimination depends on tumor coverage and normal‐cell stress. We analyzed 809 tumors and 523 adjacent‐normal specimens from eight CPTAC cohorts.
Takehiro Ishikawa
wiley   +1 more source

Pelvic inflammatory disease and risk of borderline ovarian tumors: A national population-based case-control study in Sweden. [PDF]

Int J Cancer
Jonsson S, Jonsson H, Lundin E, Häggström C, Idahl A.   +4 more
europepmc   +1 more source

Evaluation of Mutation Risk Using Patient‐Derived Organoids in Patients With Lynch Syndrome

International Journal of Cancer, Volume 159, Issue 10, Page 2585-2594, 15 November 2026.
ABSTRACT Lynch syndrome (LS) is a hereditary cancer predisposition syndrome caused by germline mutation of DNA mismatch repair (MMR) genes, most notably associated with colorectal cancer. Although LS patients face high risk of CRC, risk can vary even among those with the same pathogenic MMR germline mutations. We suggest a functional assay platform for
Youmi Shin, Dong Keon Kim, Yoojeong Seo, Hyeon Hee Lee, Jihye Park, Soo Jung Park, Jae Jun Park, Jae Hee Cheon, Jongwon Oh, Sanghoo Lee, Tae Il Kim   +10 more
wiley   +1 more source

Laparoscopic Fertility-Sparing Management of Borderline Ovarian Tumors: Surgical and Long-Term Oncological Outcomes. [PDF]

J Clin Med
Tortajada Valle M, Agustí N, Fusté P, Mensión E, Díaz-Feijóo B, Glickman A, Marina T, Torné A.   +7 more
europepmc   +1 more source

Borderline Ovarian Mucinous Tumor [PDF]

, 2020
openaire   +1 more source